ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Small Molecule Drug CDMO Market Research Report 2025
Published Date: April 2025
|
Report Code: QYRE-Auto-1F14415
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Small Molecule Drug CDMO Market Research Report 2023
BUY CHAPTERS

Global Small Molecule Drug CDMO Market Research Report 2025

Code: QYRE-Auto-1F14415
Report
April 2025
Pages:100
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Lonza
Catalent
Thermo Fisher Scientific
Samsung Biologics
Fareva
WuXi AppTech
Wuxi Biologics
Siegfried
FUJIFILM Diosynth Biotechnologies
Asymchem
Pfizer CentreOne
Delpharm
Recipharm
AGC Pharma Chemicals
Boehringer Ingelheim
Vetter
Curia
Aenova
Porton

Small Molecule Drug CDMO Market Size

The global market for Small Molecule Drug CDMO was valued at US$ 31050 million in the year 2024 and is projected to reach a revised size of US$ 46120 million by 2031, growing at a CAGR of 5.9% during the forecast period.

Small Molecule Drug CDMO Market

Small Molecule Drug CDMO Market

A CDMO is a company dedicated to providing drug development and manufacturing services for the pharmaceutical and biotechnology industries. CDMO activities can broadly be divided into four fields: product development, manufacture of active pharmaceutical ingredients (API), manufacture of finished dosage forms (FDF) and pharma packaging.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Small Molecule Drug CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Small Molecule Drug CDMO.
The Small Molecule Drug CDMO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Small Molecule Drug CDMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Small Molecule Drug CDMO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Small Molecule Drug CDMO Market Report

Report Metric Details
Report Name Small Molecule Drug CDMO Market
Accounted market size in year US$ 31050 million
Forecasted market size in 2031 US$ 46120 million
CAGR 5.9%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • FDF CDMO
  • Packaging CDMO
  • Clinical CDMO
Segment by Application
  • Pharmaceutical Company
  • Biotechnology Company
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Lonza, Catalent, Thermo Fisher Scientific, Samsung Biologics, Fareva, WuXi AppTech, WuXi Biologics, Siegfried, FUJIFILM Diosynth Biotechnologies, Asymchem, Pfizer CentreOne, Delpharm, Recipharm, AGC Pharma Chemicals, Boehringer Ingelheim, Vetter, Curia, Aenova, Porton
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Small Molecule Drug CDMO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Small Molecule Drug CDMO Market growing?

Ans: The Small Molecule Drug CDMO Market witnessing a CAGR of 5.9% during the forecast period 2025-2031.

What is the Small Molecule Drug CDMO Market size in 2031?

Ans: The Small Molecule Drug CDMO Market size in 2031 will be US$ 46120 million.

Who are the main players in the Small Molecule Drug CDMO Market report?

Ans: The main players in the Small Molecule Drug CDMO Market are Lonza, Catalent, Thermo Fisher Scientific, Samsung Biologics, Fareva, WuXi AppTech, WuXi Biologics, Siegfried, FUJIFILM Diosynth Biotechnologies, Asymchem, Pfizer CentreOne, Delpharm, Recipharm, AGC Pharma Chemicals, Boehringer Ingelheim, Vetter, Curia, Aenova, Porton

What are the Application segmentation covered in the Small Molecule Drug CDMO Market report?

Ans: The Applications covered in the Small Molecule Drug CDMO Market report are Pharmaceutical Company, Biotechnology Company, Other

What are the Type segmentation covered in the Small Molecule Drug CDMO Market report?

Ans: The Types covered in the Small Molecule Drug CDMO Market report are FDF CDMO, Packaging CDMO, Clinical CDMO

Recommended Reports

CDMO Market Landscape

Therapeutic Modalities CDMO

Small Molecule Focus

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Small Molecule Drug CDMO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 FDF CDMO
1.2.3 Packaging CDMO
1.2.4 Clinical CDMO
1.3 Market by Application
1.3.1 Global Small Molecule Drug CDMO Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Company
1.3.3 Biotechnology Company
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Small Molecule Drug CDMO Market Perspective (2020-2031)
2.2 Global Small Molecule Drug CDMO Growth Trends by Region
2.2.1 Global Small Molecule Drug CDMO Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Small Molecule Drug CDMO Historic Market Size by Region (2020-2025)
2.2.3 Small Molecule Drug CDMO Forecasted Market Size by Region (2026-2031)
2.3 Small Molecule Drug CDMO Market Dynamics
2.3.1 Small Molecule Drug CDMO Industry Trends
2.3.2 Small Molecule Drug CDMO Market Drivers
2.3.3 Small Molecule Drug CDMO Market Challenges
2.3.4 Small Molecule Drug CDMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Small Molecule Drug CDMO Players by Revenue
3.1.1 Global Top Small Molecule Drug CDMO Players by Revenue (2020-2025)
3.1.2 Global Small Molecule Drug CDMO Revenue Market Share by Players (2020-2025)
3.2 Global Small Molecule Drug CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Small Molecule Drug CDMO Revenue
3.4 Global Small Molecule Drug CDMO Market Concentration Ratio
3.4.1 Global Small Molecule Drug CDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Small Molecule Drug CDMO Revenue in 2024
3.5 Global Key Players of Small Molecule Drug CDMO Head office and Area Served
3.6 Global Key Players of Small Molecule Drug CDMO, Product and Application
3.7 Global Key Players of Small Molecule Drug CDMO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Small Molecule Drug CDMO Breakdown Data by Type
4.1 Global Small Molecule Drug CDMO Historic Market Size by Type (2020-2025)
4.2 Global Small Molecule Drug CDMO Forecasted Market Size by Type (2026-2031)
5 Small Molecule Drug CDMO Breakdown Data by Application
5.1 Global Small Molecule Drug CDMO Historic Market Size by Application (2020-2025)
5.2 Global Small Molecule Drug CDMO Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Small Molecule Drug CDMO Market Size (2020-2031)
6.2 North America Small Molecule Drug CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Small Molecule Drug CDMO Market Size by Country (2020-2025)
6.4 North America Small Molecule Drug CDMO Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Small Molecule Drug CDMO Market Size (2020-2031)
7.2 Europe Small Molecule Drug CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Small Molecule Drug CDMO Market Size by Country (2020-2025)
7.4 Europe Small Molecule Drug CDMO Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Small Molecule Drug CDMO Market Size (2020-2031)
8.2 Asia-Pacific Small Molecule Drug CDMO Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Small Molecule Drug CDMO Market Size by Region (2020-2025)
8.4 Asia-Pacific Small Molecule Drug CDMO Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Small Molecule Drug CDMO Market Size (2020-2031)
9.2 Latin America Small Molecule Drug CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Small Molecule Drug CDMO Market Size by Country (2020-2025)
9.4 Latin America Small Molecule Drug CDMO Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Small Molecule Drug CDMO Market Size (2020-2031)
10.2 Middle East & Africa Small Molecule Drug CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Small Molecule Drug CDMO Market Size by Country (2020-2025)
10.4 Middle East & Africa Small Molecule Drug CDMO Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Details
11.1.2 Lonza Business Overview
11.1.3 Lonza Small Molecule Drug CDMO Introduction
11.1.4 Lonza Revenue in Small Molecule Drug CDMO Business (2020-2025)
11.1.5 Lonza Recent Development
11.2 Catalent
11.2.1 Catalent Company Details
11.2.2 Catalent Business Overview
11.2.3 Catalent Small Molecule Drug CDMO Introduction
11.2.4 Catalent Revenue in Small Molecule Drug CDMO Business (2020-2025)
11.2.5 Catalent Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Details
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Small Molecule Drug CDMO Introduction
11.3.4 Thermo Fisher Scientific Revenue in Small Molecule Drug CDMO Business (2020-2025)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Samsung Biologics
11.4.1 Samsung Biologics Company Details
11.4.2 Samsung Biologics Business Overview
11.4.3 Samsung Biologics Small Molecule Drug CDMO Introduction
11.4.4 Samsung Biologics Revenue in Small Molecule Drug CDMO Business (2020-2025)
11.4.5 Samsung Biologics Recent Development
11.5 Fareva
11.5.1 Fareva Company Details
11.5.2 Fareva Business Overview
11.5.3 Fareva Small Molecule Drug CDMO Introduction
11.5.4 Fareva Revenue in Small Molecule Drug CDMO Business (2020-2025)
11.5.5 Fareva Recent Development
11.6 WuXi AppTech
11.6.1 WuXi AppTech Company Details
11.6.2 WuXi AppTech Business Overview
11.6.3 WuXi AppTech Small Molecule Drug CDMO Introduction
11.6.4 WuXi AppTech Revenue in Small Molecule Drug CDMO Business (2020-2025)
11.6.5 WuXi AppTech Recent Development
11.7 WuXi Biologics
11.7.1 WuXi Biologics Company Details
11.7.2 WuXi Biologics Business Overview
11.7.3 WuXi Biologics Small Molecule Drug CDMO Introduction
11.7.4 WuXi Biologics Revenue in Small Molecule Drug CDMO Business (2020-2025)
11.7.5 WuXi Biologics Recent Development
11.8 Siegfried
11.8.1 Siegfried Company Details
11.8.2 Siegfried Business Overview
11.8.3 Siegfried Small Molecule Drug CDMO Introduction
11.8.4 Siegfried Revenue in Small Molecule Drug CDMO Business (2020-2025)
11.8.5 Siegfried Recent Development
11.9 FUJIFILM Diosynth Biotechnologies
11.9.1 FUJIFILM Diosynth Biotechnologies Company Details
11.9.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.9.3 FUJIFILM Diosynth Biotechnologies Small Molecule Drug CDMO Introduction
11.9.4 FUJIFILM Diosynth Biotechnologies Revenue in Small Molecule Drug CDMO Business (2020-2025)
11.9.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.10 Asymchem
11.10.1 Asymchem Company Details
11.10.2 Asymchem Business Overview
11.10.3 Asymchem Small Molecule Drug CDMO Introduction
11.10.4 Asymchem Revenue in Small Molecule Drug CDMO Business (2020-2025)
11.10.5 Asymchem Recent Development
11.11 Pfizer CentreOne
11.11.1 Pfizer CentreOne Company Details
11.11.2 Pfizer CentreOne Business Overview
11.11.3 Pfizer CentreOne Small Molecule Drug CDMO Introduction
11.11.4 Pfizer CentreOne Revenue in Small Molecule Drug CDMO Business (2020-2025)
11.11.5 Pfizer CentreOne Recent Development
11.12 Delpharm
11.12.1 Delpharm Company Details
11.12.2 Delpharm Business Overview
11.12.3 Delpharm Small Molecule Drug CDMO Introduction
11.12.4 Delpharm Revenue in Small Molecule Drug CDMO Business (2020-2025)
11.12.5 Delpharm Recent Development
11.13 Recipharm
11.13.1 Recipharm Company Details
11.13.2 Recipharm Business Overview
11.13.3 Recipharm Small Molecule Drug CDMO Introduction
11.13.4 Recipharm Revenue in Small Molecule Drug CDMO Business (2020-2025)
11.13.5 Recipharm Recent Development
11.14 AGC Pharma Chemicals
11.14.1 AGC Pharma Chemicals Company Details
11.14.2 AGC Pharma Chemicals Business Overview
11.14.3 AGC Pharma Chemicals Small Molecule Drug CDMO Introduction
11.14.4 AGC Pharma Chemicals Revenue in Small Molecule Drug CDMO Business (2020-2025)
11.14.5 AGC Pharma Chemicals Recent Development
11.15 Boehringer Ingelheim
11.15.1 Boehringer Ingelheim Company Details
11.15.2 Boehringer Ingelheim Business Overview
11.15.3 Boehringer Ingelheim Small Molecule Drug CDMO Introduction
11.15.4 Boehringer Ingelheim Revenue in Small Molecule Drug CDMO Business (2020-2025)
11.15.5 Boehringer Ingelheim Recent Development
11.16 Vetter
11.16.1 Vetter Company Details
11.16.2 Vetter Business Overview
11.16.3 Vetter Small Molecule Drug CDMO Introduction
11.16.4 Vetter Revenue in Small Molecule Drug CDMO Business (2020-2025)
11.16.5 Vetter Recent Development
11.17 Curia
11.17.1 Curia Company Details
11.17.2 Curia Business Overview
11.17.3 Curia Small Molecule Drug CDMO Introduction
11.17.4 Curia Revenue in Small Molecule Drug CDMO Business (2020-2025)
11.17.5 Curia Recent Development
11.18 Aenova
11.18.1 Aenova Company Details
11.18.2 Aenova Business Overview
11.18.3 Aenova Small Molecule Drug CDMO Introduction
11.18.4 Aenova Revenue in Small Molecule Drug CDMO Business (2020-2025)
11.18.5 Aenova Recent Development
11.19 Porton
11.19.1 Porton Company Details
11.19.2 Porton Business Overview
11.19.3 Porton Small Molecule Drug CDMO Introduction
11.19.4 Porton Revenue in Small Molecule Drug CDMO Business (2020-2025)
11.19.5 Porton Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Lonza
Catalent
Thermo Fisher Scientific
Samsung Biologics
Fareva
WuXi AppTech
Wuxi Biologics
Siegfried
FUJIFILM Diosynth Biotechnologies
Asymchem
Pfizer CentreOne
Delpharm
Recipharm
AGC Pharma Chemicals
Boehringer Ingelheim
Vetter
Curia
Aenova
Porton
List of Tables
 Table 1. Global Small Molecule Drug CDMO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of FDF CDMO
 Table 3. Key Players of Packaging CDMO
 Table 4. Key Players of Clinical CDMO
 Table 5. Global Small Molecule Drug CDMO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Small Molecule Drug CDMO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Small Molecule Drug CDMO Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Small Molecule Drug CDMO Market Share by Region (2020-2025)
 Table 9. Global Small Molecule Drug CDMO Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Small Molecule Drug CDMO Market Share by Region (2026-2031)
 Table 11. Small Molecule Drug CDMO Market Trends
 Table 12. Small Molecule Drug CDMO Market Drivers
 Table 13. Small Molecule Drug CDMO Market Challenges
 Table 14. Small Molecule Drug CDMO Market Restraints
 Table 15. Global Small Molecule Drug CDMO Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Small Molecule Drug CDMO Market Share by Players (2020-2025)
 Table 17. Global Top Small Molecule Drug CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Drug CDMO as of 2024)
 Table 18. Ranking of Global Top Small Molecule Drug CDMO Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Small Molecule Drug CDMO Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Small Molecule Drug CDMO, Headquarters and Area Served
 Table 21. Global Key Players of Small Molecule Drug CDMO, Product and Application
 Table 22. Global Key Players of Small Molecule Drug CDMO, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Small Molecule Drug CDMO Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Small Molecule Drug CDMO Revenue Market Share by Type (2020-2025)
 Table 26. Global Small Molecule Drug CDMO Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Small Molecule Drug CDMO Revenue Market Share by Type (2026-2031)
 Table 28. Global Small Molecule Drug CDMO Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Small Molecule Drug CDMO Revenue Market Share by Application (2020-2025)
 Table 30. Global Small Molecule Drug CDMO Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Small Molecule Drug CDMO Revenue Market Share by Application (2026-2031)
 Table 32. North America Small Molecule Drug CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Small Molecule Drug CDMO Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Small Molecule Drug CDMO Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Small Molecule Drug CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Small Molecule Drug CDMO Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Small Molecule Drug CDMO Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Small Molecule Drug CDMO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Small Molecule Drug CDMO Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Small Molecule Drug CDMO Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Small Molecule Drug CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Small Molecule Drug CDMO Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Small Molecule Drug CDMO Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Small Molecule Drug CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Small Molecule Drug CDMO Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Small Molecule Drug CDMO Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Lonza Company Details
 Table 48. Lonza Business Overview
 Table 49. Lonza Small Molecule Drug CDMO Product
 Table 50. Lonza Revenue in Small Molecule Drug CDMO Business (2020-2025) & (US$ Million)
 Table 51. Lonza Recent Development
 Table 52. Catalent Company Details
 Table 53. Catalent Business Overview
 Table 54. Catalent Small Molecule Drug CDMO Product
 Table 55. Catalent Revenue in Small Molecule Drug CDMO Business (2020-2025) & (US$ Million)
 Table 56. Catalent Recent Development
 Table 57. Thermo Fisher Scientific Company Details
 Table 58. Thermo Fisher Scientific Business Overview
 Table 59. Thermo Fisher Scientific Small Molecule Drug CDMO Product
 Table 60. Thermo Fisher Scientific Revenue in Small Molecule Drug CDMO Business (2020-2025) & (US$ Million)
 Table 61. Thermo Fisher Scientific Recent Development
 Table 62. Samsung Biologics Company Details
 Table 63. Samsung Biologics Business Overview
 Table 64. Samsung Biologics Small Molecule Drug CDMO Product
 Table 65. Samsung Biologics Revenue in Small Molecule Drug CDMO Business (2020-2025) & (US$ Million)
 Table 66. Samsung Biologics Recent Development
 Table 67. Fareva Company Details
 Table 68. Fareva Business Overview
 Table 69. Fareva Small Molecule Drug CDMO Product
 Table 70. Fareva Revenue in Small Molecule Drug CDMO Business (2020-2025) & (US$ Million)
 Table 71. Fareva Recent Development
 Table 72. WuXi AppTech Company Details
 Table 73. WuXi AppTech Business Overview
 Table 74. WuXi AppTech Small Molecule Drug CDMO Product
 Table 75. WuXi AppTech Revenue in Small Molecule Drug CDMO Business (2020-2025) & (US$ Million)
 Table 76. WuXi AppTech Recent Development
 Table 77. WuXi Biologics Company Details
 Table 78. WuXi Biologics Business Overview
 Table 79. WuXi Biologics Small Molecule Drug CDMO Product
 Table 80. WuXi Biologics Revenue in Small Molecule Drug CDMO Business (2020-2025) & (US$ Million)
 Table 81. WuXi Biologics Recent Development
 Table 82. Siegfried Company Details
 Table 83. Siegfried Business Overview
 Table 84. Siegfried Small Molecule Drug CDMO Product
 Table 85. Siegfried Revenue in Small Molecule Drug CDMO Business (2020-2025) & (US$ Million)
 Table 86. Siegfried Recent Development
 Table 87. FUJIFILM Diosynth Biotechnologies Company Details
 Table 88. FUJIFILM Diosynth Biotechnologies Business Overview
 Table 89. FUJIFILM Diosynth Biotechnologies Small Molecule Drug CDMO Product
 Table 90. FUJIFILM Diosynth Biotechnologies Revenue in Small Molecule Drug CDMO Business (2020-2025) & (US$ Million)
 Table 91. FUJIFILM Diosynth Biotechnologies Recent Development
 Table 92. Asymchem Company Details
 Table 93. Asymchem Business Overview
 Table 94. Asymchem Small Molecule Drug CDMO Product
 Table 95. Asymchem Revenue in Small Molecule Drug CDMO Business (2020-2025) & (US$ Million)
 Table 96. Asymchem Recent Development
 Table 97. Pfizer CentreOne Company Details
 Table 98. Pfizer CentreOne Business Overview
 Table 99. Pfizer CentreOne Small Molecule Drug CDMO Product
 Table 100. Pfizer CentreOne Revenue in Small Molecule Drug CDMO Business (2020-2025) & (US$ Million)
 Table 101. Pfizer CentreOne Recent Development
 Table 102. Delpharm Company Details
 Table 103. Delpharm Business Overview
 Table 104. Delpharm Small Molecule Drug CDMO Product
 Table 105. Delpharm Revenue in Small Molecule Drug CDMO Business (2020-2025) & (US$ Million)
 Table 106. Delpharm Recent Development
 Table 107. Recipharm Company Details
 Table 108. Recipharm Business Overview
 Table 109. Recipharm Small Molecule Drug CDMO Product
 Table 110. Recipharm Revenue in Small Molecule Drug CDMO Business (2020-2025) & (US$ Million)
 Table 111. Recipharm Recent Development
 Table 112. AGC Pharma Chemicals Company Details
 Table 113. AGC Pharma Chemicals Business Overview
 Table 114. AGC Pharma Chemicals Small Molecule Drug CDMO Product
 Table 115. AGC Pharma Chemicals Revenue in Small Molecule Drug CDMO Business (2020-2025) & (US$ Million)
 Table 116. AGC Pharma Chemicals Recent Development
 Table 117. Boehringer Ingelheim Company Details
 Table 118. Boehringer Ingelheim Business Overview
 Table 119. Boehringer Ingelheim Small Molecule Drug CDMO Product
 Table 120. Boehringer Ingelheim Revenue in Small Molecule Drug CDMO Business (2020-2025) & (US$ Million)
 Table 121. Boehringer Ingelheim Recent Development
 Table 122. Vetter Company Details
 Table 123. Vetter Business Overview
 Table 124. Vetter Small Molecule Drug CDMO Product
 Table 125. Vetter Revenue in Small Molecule Drug CDMO Business (2020-2025) & (US$ Million)
 Table 126. Vetter Recent Development
 Table 127. Curia Company Details
 Table 128. Curia Business Overview
 Table 129. Curia Small Molecule Drug CDMO Product
 Table 130. Curia Revenue in Small Molecule Drug CDMO Business (2020-2025) & (US$ Million)
 Table 131. Curia Recent Development
 Table 132. Aenova Company Details
 Table 133. Aenova Business Overview
 Table 134. Aenova Small Molecule Drug CDMO Product
 Table 135. Aenova Revenue in Small Molecule Drug CDMO Business (2020-2025) & (US$ Million)
 Table 136. Aenova Recent Development
 Table 137. Porton Company Details
 Table 138. Porton Business Overview
 Table 139. Porton Small Molecule Drug CDMO Product
 Table 140. Porton Revenue in Small Molecule Drug CDMO Business (2020-2025) & (US$ Million)
 Table 141. Porton Recent Development
 Table 142. Research Programs/Design for This Report
 Table 143. Key Data Information from Secondary Sources
 Table 144. Key Data Information from Primary Sources
 Table 145. Authors List of This Report


List of Figures
 Figure 1. Small Molecule Drug CDMO Picture
 Figure 2. Global Small Molecule Drug CDMO Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Small Molecule Drug CDMO Market Share by Type: 2024 VS 2031
 Figure 4. FDF CDMO Features
 Figure 5. Packaging CDMO Features
 Figure 6. Clinical CDMO Features
 Figure 7. Global Small Molecule Drug CDMO Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Small Molecule Drug CDMO Market Share by Application: 2024 VS 2031
 Figure 9. Pharmaceutical Company Case Studies
 Figure 10. Biotechnology Company Case Studies
 Figure 11. Other Case Studies
 Figure 12. Small Molecule Drug CDMO Report Years Considered
 Figure 13. Global Small Molecule Drug CDMO Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Small Molecule Drug CDMO Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Small Molecule Drug CDMO Market Share by Region: 2024 VS 2031
 Figure 16. Global Small Molecule Drug CDMO Market Share by Players in 2024
 Figure 17. Global Top Small Molecule Drug CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Drug CDMO as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Small Molecule Drug CDMO Revenue in 2024
 Figure 19. North America Small Molecule Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Small Molecule Drug CDMO Market Share by Country (2020-2031)
 Figure 21. United States Small Molecule Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Small Molecule Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Small Molecule Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Small Molecule Drug CDMO Market Share by Country (2020-2031)
 Figure 25. Germany Small Molecule Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Small Molecule Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Small Molecule Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Small Molecule Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Small Molecule Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Small Molecule Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Small Molecule Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Small Molecule Drug CDMO Market Share by Region (2020-2031)
 Figure 33. China Small Molecule Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Small Molecule Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Small Molecule Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Small Molecule Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Small Molecule Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Small Molecule Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Small Molecule Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Small Molecule Drug CDMO Market Share by Country (2020-2031)
 Figure 41. Mexico Small Molecule Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Small Molecule Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Small Molecule Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Small Molecule Drug CDMO Market Share by Country (2020-2031)
 Figure 45. Turkey Small Molecule Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Small Molecule Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Small Molecule Drug CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Lonza Revenue Growth Rate in Small Molecule Drug CDMO Business (2020-2025)
 Figure 49. Catalent Revenue Growth Rate in Small Molecule Drug CDMO Business (2020-2025)
 Figure 50. Thermo Fisher Scientific Revenue Growth Rate in Small Molecule Drug CDMO Business (2020-2025)
 Figure 51. Samsung Biologics Revenue Growth Rate in Small Molecule Drug CDMO Business (2020-2025)
 Figure 52. Fareva Revenue Growth Rate in Small Molecule Drug CDMO Business (2020-2025)
 Figure 53. WuXi AppTech Revenue Growth Rate in Small Molecule Drug CDMO Business (2020-2025)
 Figure 54. WuXi Biologics Revenue Growth Rate in Small Molecule Drug CDMO Business (2020-2025)
 Figure 55. Siegfried Revenue Growth Rate in Small Molecule Drug CDMO Business (2020-2025)
 Figure 56. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Small Molecule Drug CDMO Business (2020-2025)
 Figure 57. Asymchem Revenue Growth Rate in Small Molecule Drug CDMO Business (2020-2025)
 Figure 58. Pfizer CentreOne Revenue Growth Rate in Small Molecule Drug CDMO Business (2020-2025)
 Figure 59. Delpharm Revenue Growth Rate in Small Molecule Drug CDMO Business (2020-2025)
 Figure 60. Recipharm Revenue Growth Rate in Small Molecule Drug CDMO Business (2020-2025)
 Figure 61. AGC Pharma Chemicals Revenue Growth Rate in Small Molecule Drug CDMO Business (2020-2025)
 Figure 62. Boehringer Ingelheim Revenue Growth Rate in Small Molecule Drug CDMO Business (2020-2025)
 Figure 63. Vetter Revenue Growth Rate in Small Molecule Drug CDMO Business (2020-2025)
 Figure 64. Curia Revenue Growth Rate in Small Molecule Drug CDMO Business (2020-2025)
 Figure 65. Aenova Revenue Growth Rate in Small Molecule Drug CDMO Business (2020-2025)
 Figure 66. Porton Revenue Growth Rate in Small Molecule Drug CDMO Business (2020-2025)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Pharmaceutical CDMO Market Research Report 2025
Pharmaceutical CMO and CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Small Molecules CDMO Services Market Research Report 2024
Global Small Molecule Drug CDMO Services Market Research Report 2024
Global Chemical Drug CDMO Market Research Report 2024
Global Full Service CDMO Market Research Report 2024
Global Pharmaceutical Contract Development and Manufacturing Organization Market Research Report 2025
Global Chemical CDMO Market Research Report 2024
Pharmaceutical CDMO Solution Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Contract Dose Manufacturing Market Insights Forecast to 2030
Global Formulation CDMO Services Market Research Report 2024
Pharmaceutical CDMO Services Market
Global Large Molecule Drug Substance CDMO Market Research Report 2024
Active Pharmaceutical Ingredients API CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antibody Drug CDMO Service Market Research Report 2024
Global Biopharmaceutical CDMO Market Research Report 2025
Active Pharmaceutical Ingredients CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Biopharmaceutical CDMO Service Market Research Report 2024
Global Biological Drug CDMO Market Research Report 2024
Global Topical Drugs CDMO Market Research Report 2025

RELATED REPORTS

Global Cephalosporin APIs and Cephalosporin Intermediates Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19G16926
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global ELISA Immunoassay Plates Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-7Z17064
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Ready-to-Use ELISA Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20P20045
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Moxidectin Injection Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3Z19977
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions